Monitoring of clozapine-induced myocarditis

Australasian Psychiatry

Volumn 17, Issue 5, 2009, Pages 421-

  Caetano, Dorgival ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CLOZAPINE; CREATINE KINASE; GLUCOSE; OLANZAPINE; RISPERIDONE; TROPONIN I; TROPONIN T; VALPROIC ACID;

ADULT; AUSTRALIA; BLOOD EXAMINATION; CASE REPORT; DIARRHEA; DISEASE PREDISPOSITION; DRUG DOSE INCREASE; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; GLUCOSE BLOOD LEVEL; HUMAN; LETTER; MALE; MYOCARDITIS; NAUSEA; PARANOID SCHIZOPHRENIA; PATIENT MONITORING;

ADULT; CLOZAPINE; DRUG MONITORING; HUMANS; MALE; MYOCARDITIS; TROPONIN I;

EID: 70849125132     PISSN: 10398562     EISSN: 14401665     Source Type: Journal    
DOI: 10.1080/10398560903176941     Document Type: Letter

References (5)

1. Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Archives of General Psychiatry 2003; 60: 553-564.
2. Reinders J, Parsonage W, Lange D, Potter J, Plever S. Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service. Australian and New Zealand Journal of Psychiatry 2004; 38: 915-922.
3. Caetano D, Gandi C. Clozapine-induced myocarditis. Australian and New Zealand Journal of Psychiatry 2008; 42: 434-435.
4. Berk M, Fitzsimons J, Lambert T et al. Monitoring the safe use of clozapine: a consensus view from Victoria, Australia. CNS Drugs 2007; 21: 117-127.
5. Clopine Connect: Your Dedicated Support Network. Melbourne: Hospira Australia Pty Ltd